短期抗甲状腺药物治疗与抗中性粒细胞胞浆抗体关系的研究(3)
5 Slot MC,Links TP,Stegeman CA,et al.Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs：a long-term follow-up study.Arthritis Rheum,2005,53(1)：108-113.
6 Guma M,Salinas I,Reverter JL,et al.Frequency of antineutrophil cytoplasmic antibody in graves disease patients Treated with methimazole.The Journal of Clinical Endocrinology and Metabolism,2003,88(5)：2141-2146.
7 Wiik A.Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.APMIS,1989,6：12-13.
8 Tanemoto M,Miyakawa H,Hanai J,et al.Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves’disease：report of three adult cases.American Joumal of Kidney Diseases,1995，26：774-780.
9 Noh JY,Asari T,Hamada N,et al.Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)in Graves disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.Clinical Endocrino1ogy(Oxf),2001,54(5)：651-654.
10 Wada N,Mukai M,Kohno M，et al.Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies(MPO-ANCA)in patients with Graves disease treated with pmpylthiouracil and thiamazole.Endocrine Journal,2002,49(3)：329-334.
11 徐旭东,赵明辉,章友康,等.丙基硫氧嘧啶导致的抗中性粒细胞胞质抗体阳性小血管炎及其靶抗原研究.中华内科杂志，2002,41(6)：404-407., 百拇医药(徐 华 池莲祥 文杏珠 李新强)
6 Guma M,Salinas I,Reverter JL,et al.Frequency of antineutrophil cytoplasmic antibody in graves disease patients Treated with methimazole.The Journal of Clinical Endocrinology and Metabolism,2003,88(5)：2141-2146.
7 Wiik A.Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.APMIS,1989,6：12-13.
8 Tanemoto M,Miyakawa H,Hanai J,et al.Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves’disease：report of three adult cases.American Joumal of Kidney Diseases,1995，26：774-780.
9 Noh JY,Asari T,Hamada N,et al.Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)in Graves disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.Clinical Endocrino1ogy(Oxf),2001,54(5)：651-654.
10 Wada N,Mukai M,Kohno M，et al.Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies(MPO-ANCA)in patients with Graves disease treated with pmpylthiouracil and thiamazole.Endocrine Journal,2002,49(3)：329-334.
11 徐旭东,赵明辉,章友康,等.丙基硫氧嘧啶导致的抗中性粒细胞胞质抗体阳性小血管炎及其靶抗原研究.中华内科杂志，2002,41(6)：404-407., 百拇医药(徐 华 池莲祥 文杏珠 李新强)